{
    "organizations": [],
    "uuid": "98387439f56370b5c0862d63af9b7e59a17ed445",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oncocyte-announces-initial-results/brief-oncocyte-announces-initial-results-of-determavu-feasibility-on-new-platforms-idUSFWN1QQ10Q",
    "ord_in_thread": 0,
    "title": "BRIEF-Oncocyte Announces Initial Results Of Determavu™ Feasibility On New Platforms",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Oncocyte Corp:\n* ONCOCYTE ANNOUNCES INITIAL RESULTS OF DETERMAVU™ FEASIBILITY ON NEW PLATFORMS; ENHANCEMENTS MAY INCREASE LUNG CANCER DIAGNOSTIC TEST’S CLINICAL PERFORMANCE\n* ONCOCYTE CORP - CO IS ACTIVELY EVALUATING ALTERNATIVE ASSAY PLATFORMS FOR USE WITH MOLECULAR BIOLOGY DIAGNOSTIC TESTING​\n* ONCOCYTE CORP - ‍INITIAL RESULTS SHOW ILLUMINA PLATFORM COULD PROVIDE SUPPORT FOR CLINICAL DEVELOPMENT STUDIES NECESSARY FOR DETERMAVU​ COMMERCIALIZATION\n* ONCOCYTE CORP - ‍ONCOCYTE HAS ALSO IDENTIFIED WAYS THAT POTENTIALLY MAY ENHANCE LUNG CANCER SIGNAL IDENTIFIED BY DETERMAVU​\n* ONCOCYTE - CO EXTENDING EVALUATION OF COMMERCIAL MOLECULAR DIAGNOSTIC PLATFORMS BY DOING A FOLLOW-ON STUDY UTILIZING LARGER SET OF CLINICAL SAMPLES​ Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-09T05:42:00.000+02:00",
    "crawled": "2018-03-09T14:32:13.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "oncocyte",
        "corp",
        "oncocyte",
        "announces",
        "initial",
        "result",
        "feasibility",
        "new",
        "platform",
        "enhancement",
        "may",
        "increase",
        "lung",
        "cancer",
        "diagnostic",
        "test",
        "clinical",
        "performance",
        "oncocyte",
        "corp",
        "co",
        "actively",
        "evaluating",
        "alternative",
        "assay",
        "platform",
        "use",
        "molecular",
        "biology",
        "diagnostic",
        "oncocyte",
        "corp",
        "result",
        "show",
        "illumina",
        "platform",
        "could",
        "provide",
        "support",
        "clinical",
        "development",
        "study",
        "necessary",
        "commercialization",
        "oncocyte",
        "corp",
        "also",
        "identified",
        "way",
        "potentially",
        "may",
        "enhance",
        "lung",
        "cancer",
        "signal",
        "identified",
        "oncocyte",
        "co",
        "extending",
        "evaluation",
        "commercial",
        "molecular",
        "diagnostic",
        "platform",
        "study",
        "utilizing",
        "larger",
        "set",
        "clinical",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}